|
|
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)
Marwân-Al-Qays Bousmah
,
Marie Libérée Nishimwe
,
Tamara Tovar-Sanchez
,
Martial Lantche Wandji
,
Mireille Mpoudi-Etame
,
et al.
Article dans une revue
hal-03174666v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Long‐term clinical benefits of Sofosbuvir‐based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa
Mael Baudoin
,
Maame Esi Woode
,
Marie Libérée Nishimwe
,
Maud Lemoine
,
Babacar Sylla
,
et al.
Article dans une revue
inserm-03121819v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Cost‑Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV‑1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)
Osvaldo Ulises Garay
,
Marie Libérée Nishimwe
,
Marwân-Al-Qays Bousmah
,
Asmaa Janah
,
Pierre-Marie Girard
,
et al.
Article dans une revue
inserm-02272394v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Population attributable fractions of mortality in people living with HIV: roles of delayed antiretroviral therapy, hepatitis coinfections and social factors
Melina Santos
,
Camelia Protopopescu
,
Rachel Ribeiro
,
Adele Benzaken
,
Gerson Pereira
,
et al.
Article dans une revue
inserm-03104215v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|